Boston Scientific Boosts Patent Portfolio with BTG Acquisition

British Technology Group (now BTG plc), known for producing drugs to treat overdoses and rattlesnake bites, was formed in 1981 as a result of the merger of the National Research & Development Council and the National Enterprise Board of the UK government. A range of medical innovations along the way and several acquisitions later, BTG today is an international healthcare company focused on interventional medicine.

In late November 2018, Boston Scientific Corporation (BSC) announced that it would be acquiring BTG plc for USD 4.2 billion. Boston Scientific manufactures medical devices with interventional medical specialities. The acquisition will help Boston Scientific enhance its technology coverage and capabilities in interventional medicine.

In this report, we take a closer look at the patent portfolios of BTG and BSC using the taxonomy analytics generated by Relecura.

An Overview

Figure 1: BTG – Published Applications – Growth [Click on the image to enlarge]

BTG owns a patent portfolio of 1,487 active applications, which is about 9% the number of the total patent assets held by BSC (16,849 active applications). Figure 1 gives the publication trend of BTG’s patent portfolio.

Figure 2: BTG – Interventional Devices – Growth [Click on the image to enlarge]

BTG has a relatively small patent portfolio. However, the patent assets related to interventional medicine and devices in its portfolio are of high quality. Figure 2 depicts the growth of its published patent assets covering interventional devices.

The report includes a detailed comparison of the portfolios of BTG and BSC. The comparison determines the value that acquiring BTG’s portfolio brings to BSC’s current patent assets. It shows how well the patent portfolios of both the companies complement each other and takes a closer look at the patent quality of the assets held by each.

The report considers the different M&A IP scenarios that might have played out. These include attempting to determine which other companies could have been potential acquirers for BTG. On the flip side, it analyzes other options that Boston Scientific might have considered as potential acquisitions, that were comparable to BTG from an IP standpoint.

Read our report to get all the analysis details and insights.

Get the complete report here.

Discover insights faster!

The contents of this report were referenced in an IAM article. To read the article, click here.
Home > Boston Scientific Boosts Patent Portfolio with BTG Acquisition
A custom built AI Platform to support, generate, and manage innovation

Streamline your innovation ecosystem through the assimilation of the latest AI capabilities for a competitive edge.

  • AI powered custom solutions for Innovation Intelligence
  • Automation of competitor analysis
  • Identification of emerging technologies and companies
  • Whitespace Analysis and Potential M&A Targets
  • Strategic decision making supported by real-time data

Drive growth through insights that matter

Investment management

The dilemma of where, when, and how much to invest in the innovation space is a critical factor...

Know More

Due Diligence

M&A is a strategic process, aimed at a mutually supportive and complementary association, resulting in a synergized end...

Know More


Innovation reaches a dead-end if it cannot be monetized when the innovator fails to trace and reach out...

Know More

Portfolio organization

Management of IP assets is costly and labor-intensive. Relecura offers classifier tools for categorizing and organizing data automatically...

Know More

AI Platform for innovation intelligence

Relecura’s forte is its flexibility and adaptability to address specific problems and close-fitting solutions. The basic problem is that innovators are often not able to identify the industrial and commercial significance of their innovation as due diligence takes long days of analyses, necessitating a deviation from their regular and familiar activities. And it is a tedious iteration process. The latest custom AI capabilities help you assess the commercial value of innovation and technical due diligence can be automated to yield meaningful and immediate results. The repetitive tasks could be automated, and your time and energy could be devoted to strategic missions.

Portfolio organization

Management of large Innovation data is costly and labor intensive. Relecura offers AI-powered classification tools for categorizing and organizing data automatically and instantly. Automated Categorization against suitably chosen training documents keeps your innovation portfolio updated and lucidly classified, amenable to instant analyses.

Technology trends

Relecura offers fully automated custom AI solutions to track and explore developments in different technology areas. You can stay updated on the latest developments in different companies and technologies of your interest, which facilitates intelligent decision-making.

Competitive intelligence

Competitive intelligence is a prerequisite for strategic decision making. Relecura provides tools to track the innovation and publication dynamics of your competitors, based on which you can prioritize your innovation initiatives and thus hone up your competitive edge.

Investment Management

Relecura uses white space analysis within its product platform known as the TechTracker, an AI-powered tool that provides insights on various technological trends and offers a peep into your competitor’s patent arsenal. Additionally, it helps you keep track of emerging organizations and technologies to help you manage your budgets and investments, optimally.

What our valuable customers are
saying about us?

“Relecura helps us remain innovative by allowing us to see where the competition is playing through the landscaping tools. It lets us see where there are new opportunities and helps us focus in on those areas in an intelligent way.”


Alex M.,
IP Manager, a Multinational Technology Corporation, US

Relecura helps us ride the crest of innovation wave keeping a competitive edge.” It helps us identify the white spaces and where the opportunities are.”

John N,
Director of IP at a Global Data Storage & Semiconductor Company, US

‘Our policy decisions regarding the focus areas of research and investment are being taken based on the insights offered by the custom AI tool, TechTracker, which offers a clear picture about the emerging technologies, companies, and the white spaces on the technology landscape of the key players. This helps us optimize resource utilization and maximize returns,’

Subu N.,
Innovation Manager at an Indian Conglomerate, India

‘The Classifier tool, introduced by Relecura, is indeed useful in managing and updating large datasets. After having subscribed to that AI-powered tool, in-house big data management and analyses have become easier and hassle-free.”

Fabian L.,
R&D, a Global Semiconductor Company, US

“Relecura platform is fueled by the latest technologies, and the tools that the platform hosts make our in-house innovation management smooth and accurate, in addition to being synchronized with the global technology frontline.”

Viktor P.,
Innovation Strategy at a Global Consumer Product Company, South Korea

Recent Blog Posts

Make faster, better technology decisions with Relecura

Connect with our Specialists

Our professional services offer training and support to minimise time-to-value on the Relecura platform and make more timely, confident IP decisions